The ADMA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADMA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ADMA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ADMA Detailed Price Forecast - CNN Money||View ADMA Detailed Summary - Google Finance|
|View ADMA Detailed Summary - Yahoo! Finance||View ADMA Stock Research & Analysis - Zacks.com|
|View ADMA Trends & Analysis - Trade-Ideas||View ADMA Major Holders - Barrons|
|View ADMA Call Transcripts - NASDAQ||View ADMA Breaking News & Analysis - Seeking Alpha|
|View ADMA Annual Report - CompanySpotlight.com||View ADMA OTC Short Report - OTCShortReport.com|
|View ADMA Fundamentals - TradeKing||View ADMA SEC Filings - Bar Chart|
|View Historical Prices for ADMA - The WSJ||View Performance/Total Return for ADMA - Morningstar|
|View the Analyst Estimates for ADMA - MarketWatch||View the Earnings History for ADMA - CNBC|
|View the ADMA Earnings - StockMarketWatch||View ADMA Buy or Sell Recommendations - MacroAxis|
|View the ADMA Bullish Patterns - American Bulls||View ADMA Short Pain Metrics - ShortPainBot.com|
|View ADMA Stock Mentions - StockTwits||View ADMA Stock Mentions - PennyStockTweets|
|View ADMA Stock Mentions - Twitter||View ADMA Investment Forum News - Investor Hub|
|View ADMA Stock Mentions - Yahoo! Message Board||View ADMA Stock Mentions - Seeking Alpha|
|View Insider Transactions for ADMA - SECform4.com||View Insider Transactions for ADMA - Insider Cow|
|View ADMA Major Holdings Summary - CNBC||View Insider Disclosure for ADMA - OTC Markets|
|View Insider Transactions for ADMA - Yahoo! Finance||View Institutional Holdings for ADMA - NASDAQ|
|View ADMA Stock Insight & Charts - FinViz.com||View ADMA Investment Charts - StockCharts.com|
|View ADMA Stock Overview & Charts - BarChart||View ADMA User Generated Charts - Trading View|
ADMA Biologics Reports FDA Compliance Status for its Manufacturing Facility has Improved
Posted on Wednesday September 05, 2018
ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company that manufactures, markets and develops specialty plasma-based biologics for the prevention and treatment of certain infectious diseases, announces that the United States Food and Drug Administration (“FDA”) inspection database classification website has been updated and confirms ADMA’s compliance status has improved to Voluntary Action Indicated (“VAI”). “We are pleased that the FDA has acknowledged the improved current good manufacturing practice (“cGMP”) conditions at our manufacturing facility and updated its database accordingly,” stated Adam Grossman, President and Chief Executive Officer of ADMA Biologics, Inc. “We are excited to finally be in a position to resubmit our Biologics License Application (“BLA”) for RI-002 during the third quarter of 2018, which we believe is a needed Intravenous Immune Globulin (“IVIG”) option for patients who suffer with Primary Humoral Immunodeficiency Disease (“PIDD”).
Penny Stocks to Watch for September 2018
Posted on Friday August 31, 2018
Junior miners turned lower in sympathy with declining gold and silver contracts, while small biotech and medical diagnostic stocks picked up the slack, underpinned by sector funds probing new highs. September has a mixed reputation when it comes to small speculative plays, suggesting that traders focus their attention on penny stocks exhibiting the highest relative strength while avoiding falling knives that may face tax selling pressure in the fourth quarter. Low-priced energy stocks look like wild cards in this equation, with crude oil coming off lows while rising Middle East tensions add to sector buying power.
ADMA: FDA Submissions are Next Milestones
Posted on Monday August 27, 2018
ADMA Biologics, Inc. (ADMA) filed its 10-K and press release for its second quarter 2018 financial results on August 10, 2018. The highlights year to date have included the release of the first commercial batch of Nabi-HB to be manufactured under ADMA ownership, the retirement of 8.6 million shares issued to Biotest and the grant of a patent for treating respiratory infections related to RI-002. On June 12, ADMA closed $40 million in equity financing followed just over six weeks later by the successful close out of the FDA compliance inspection.
ADMA Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
Posted on Monday August 27, 2018
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 27, 2018-- ADMA Biologics, Inc., a vertically integrated commercial biopharmaceutical company that develops, manufactures and markets specialty plasma-based biologics ...